These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15005421)

  • 1. Synthesis and antiaggregatory activity of RGD-peptidomimetics based on 4-oxo-4-(piperazine-1-yl)butyric acid as Arg-mimetic.
    Andronati SA; Krysko AA; Kabanov VM; Kabanova TA; Karaseva TL; Chugunov BM; Meshkova SB; Topilova ZM
    Acta Pol Pharm; 2003; 60(5):375-81. PubMed ID: 15005421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and antiaggregative activity of a new RGDF mimetic].
    Krys'ko AA; Malovichko OL; Kabanova TA; Mazepa AV
    Bioorg Khim; 2004; 30(6):594-8. PubMed ID: 15586810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fibrinogen receptor antagonists. RGDF mimetics, derivatives of 4-(isoindoline-5-yl)amino-4-oxobutyric acid.
    Krysko AA; Chugunov BM; Malovichko OL; Andronati SA; Kabanova TA; Karaseva TL; Kiriyak AV
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5533-5. PubMed ID: 15482918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
    Andronati SA; Karaseva TL; Krysko AA
    Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.
    Krysko AA; Samoylenko GV; Polishchuk PG; Andronati SA; Kabanova TA; Khristova TM; Kuz'min VE; Kabanov VM; Krysko OL; Varnek AA; Grygorash RY
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5971-4. PubMed ID: 21852128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
    Sugihara H; Fukushi H; Miyawaki T; Imai Y; Terashita Z; Kawamura M; Fujisawa Y; Kita S
    J Med Chem; 1998 Feb; 41(4):489-502. PubMed ID: 9484499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.
    Krysko AA; Krysko OL; Kabanova TA; Andronati SA; Kabanov VM
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4444-6. PubMed ID: 20598885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiaggregatory activity of antiflammin related peptides.
    Marastoni M; Scaranari V; Salvadori S; Tomatis R; Spisani S; Traniello S
    Farmaco; 1991 Nov; 46(11):1265-72. PubMed ID: 1811615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
    Stavrakoudis A; Bizos G; Eleftheriadis D; Kouki A; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tsikaris V
    Biopolymers; 2000-2001; 56(1):20-6. PubMed ID: 11582574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents.
    Higuchi K; Hikita H; Murayama A; Yuri D; Kobayakawa N; Takahashi T; Kojima S; Ueno H; Hatakeyama T; Kato A; Tayu M; Oyama E; Sugiyama S; Ishii K; Takahashi H; Kawasaki T
    Chem Pharm Bull (Tokyo); 2016; 64(12):1726-1738. PubMed ID: 27904082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs].
    Mel'nik OV; Martinovich VP; Golubovich VP
    Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor.
    Zablocki JA; Miyano M; Garland RB; Pireh D; Schretzman L; Rao SN; Lindmark RJ; Panzer-Knodle SG; Nicholson NS; Taite BB
    J Med Chem; 1993 Jun; 36(13):1811-9. PubMed ID: 8515420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for Roxifiban.
    Mousa SA; Bozarth JM; Naik UP; Slee A
    Br J Pharmacol; 2001 Jun; 133(3):331-6. PubMed ID: 11375248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of cyclic oligopeptides containing an Arg-Gly-Asp (RGD) sequence.
    Sofuku S; Hoshida A; Shimada T; Takada Y; Takakuwa T
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1799-801. PubMed ID: 10748723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular dichroism studies of type III collagen mimetic peptides with anti- or pro-aggregant activities on human platelets.
    Pêcher J; Pires V; Djaafri I; Da Nascimento S; Fauvel-Lafève F; Legrand C; Sonnet P
    Eur J Med Chem; 2009 Jun; 44(6):2643-50. PubMed ID: 19056149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of thrombin receptor-derived nonpeptide mimetics utilizing a piperazine scaffold.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Smith J; Mavromoustakos T; Saifeddine M; Moore G; Hollenberg M; Matsoukas J
    Bioorg Med Chem; 1999 Jun; 7(6):1033-41. PubMed ID: 10428371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
    Barre DE
    Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of RGD analogs as potential vectors for targeted drug delivery.
    Jiang J; Wang W; Sane DC; Wang B
    Bioorg Chem; 2001 Dec; 29(6):357-79. PubMed ID: 11846434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A shortcut to peptides to modulate platelets.
    Apic G; Russell RB
    Nat Chem Biol; 2007 Feb; 3(2):83-4. PubMed ID: 17235341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.